RxEconomics Logo - Health Economics and Outcomes Research Consultancy specializing in AI-driven analytics

About RxEconomics

At RxEconomics LLC, we transform complex healthcare data into powerful strategic insights. Our boutique consultancy specializes in health economics and outcomes research (HEOR), combining over 27 years of rigorous analytical expertise with groundbreaking generative AI to deliver impactful, actionable solutions.

We serve pharmaceutical manufacturers, healthcare payers, pharmacy benefit managers (PBMs), government agencies, and academic institutions, empowering them to clarify strategies, optimize healthcare value, and confidently navigate critical decisions with credible, real-world evidence.

Why Work With Us

Our clients choose us—and stay with us—for three simple reasons:

Efficiency & Scale

Leveraging automation and advanced analytical tools, we deliver faster, more cost-effective results than larger firms—without sacrificing rigor or quality.

Personalized Partnership

We provide expert-level guidance and a direct, hands-on approach from day one—ensuring focused attention, clear communication, and tailored insights for your specific needs.

Proven Track Record

Our work is featured in top-tier journals like Health Affairs, Medical Care, and the American Economic Review. Clients trust us to deliver credible analyses that directly inform critical, high-stakes decisions.

About M. Christopher Roebuck, PhD

Dr. M. Christopher Roebuck - Founder and CEO of RxEconomics, PhD Health Economist specializing in pharmaceutical outcomes research and AI applications

Dr. Roebuck founded RxEconomics to bridge the gap between rigorous health economics research and real-world decision-making. With extensive experience across both academia and industry, Chris is a recognized authority in applying advanced analytics to healthcare challenges.

Before launching RxEconomics, Chris was Director of Strategic Research and Health Economist at CVS Caremark, where he shaped healthcare strategy for one of the nation's leading PBMs. His research has appeared in prestigious journals including Health Affairs, Medical Care, and the American Economic Review, reflecting his commitment to high-quality, actionable analyses.

Chris personally oversees each client engagement, ensuring every project is executed with precision, tailored insights, and exceptional efficiency. Clients consistently value his ability to translate complex data into clear, evidence-based recommendations.

Chris earned his PhD in Public Policy (Economics) from UMBC, an MBA in Finance from the University of Miami, and a BA in Economics from the University of Pennsylvania.

A Message from Chris

"My passion is turning complex health data into practical insights that improve outcomes, reduce costs, and drive innovation. At RxEconomics, I personally oversee each project to ensure you receive precise analyses tailored exactly to your strategic goals."

Ready to Accelerate Your Health Economics Strategy?

Schedule your complimentary consultation to discover how RxEconomics delivers rapid analytics, credible real-world evidence, and strategic clarity.

Request Your Consult